Cannabis Law Report

JUNE 6, 2019

In AB 228, the state, by declaring that food and cosmetics are not adulterated by the inclusion of hemp (including cannabinoids, extracts, or derivatives), essentially finds that hemp-derived products, including products containing CBD, are safe for human and animal consumption. DEA cases in the early 2000s.

Hemp 66

Hemp Legislation Food Consumption 66

MedicalJane

OCTOBER 5, 2017

Using cannabis as a medicine is not a new practice, and recent research shows that cannabis extracts may represent an efficacious and safe alternative for treatment of a wide range of conditions in women including dysmenorrhea, dysuria, hyperemesis gravidarum, and menopausal symptoms. ” – Dr. Russo.

Marijuana 65

Marijuana Treatment Extraction Medicine 65

SpeedWeed

MARCH 7, 2021

And then fast forward, I stayed in the industry and sell JULABO at all the trade shows, so they created a position for me in 2008 and I’ve been with them ever since. But now that extraction has really matured, they want lower, colder temperatures with high power, at minus 40 C for example. Is it a VAR channel?

Extraction 52

Extraction Data Hemp Research and Development 52

Cannabis Law Report

JULY 12, 2019

However, there are indications from studies done with cannabidiol-rich cannabis extracts in Israel that indicate that less side effects (46%) are achieved with a natural cannabis plant extract containing a 20:1 ratio of CBD to THC. The CBD-rich extract group had a lower effective dose on average, 6.1

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

The Cannigma

SEPTEMBER 12, 2021

Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. A lot of cannabis products are in fact regular products infused with a cannabis extraction. Isolated THC These are THC products that are based on isolated cannabis extract. Isolated THC vs full spectrum THC.

THC 98

THC Research and Development Cannabinoids CBD 98

Cannabis Law Report

MARCH 25, 2019

The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 15, 2008 , 122 Stat. 2003, 2004, 2007, 2008, Nov. 109–177, title VII , §§ ? 711(f)(1)(B), 732, Mar.

Banking 45

Banking Law Marijuana State Laws 45